direkt zum Inhalt springen

direkt zum Hauptnavigationsmenü

Sie sind hier

TU Berlin

Inhalt des Dokuments

Deutsches Gesundheitssystem

2018

  • Ex P, Felgner S, Henschke C (2018): Rechtsprechungen zur Kostenerstattung von neuen Gesundheitstechnologien in der GKV: Eine systematische Übersicht. [1]
  • Blümel M, Busse R (2018): The “Bismarck-Model”: Germany’s health insurance system in its historical context. [2]

2017

  • Stephani V, Geissler A, Busse R (2017): Kooperation und Integration von Krankenhäusern - Potentiale für disruptive Innovationen? [3]
  • Weiss B, Marschall U, Busse R, Mansmann U, Caumanns J, Rosseau S, Seeling M, Spies C (2017): ERIC – Enhanced Recovery after Intensive Care. [4]
  • Scheller-Kreinsen D, Lehmann K, Quentin W, Kaiser P Haun O (2017): Ambulant-stationäre Grenze: endlich aufräumen [5]
  • Stephani V, Sommariva S, Spranger A, Ciani O (2017): Non-communicable diseases: mapping research funding organisations, funding mechanisms and research practices in Italy and Germany. [6]

2016

  • Blümel M, Busse R (2016): The German Health Care System 2015 [7]
  • Ex P, Busse R, Henschke C (2016): Die Nutzenbewertung von nichtmedikamentösen Untersuchungs- und Behandlungsmethoden [8]
  • Siegel M, Koller D, Vogt V, Sundmacher L (2016): Developing a composite index of spatial accessibility across different health care sectors: A German example [9]
  • Vogt V (2016): The contribution of locational factors to regional variations in office-based physicians in Germany [10]

2015

  • Busse R, Panteli D, Henschke C (2015): Arzneimittelversorgung in der GKV und 15 anderen europäischen Gesundheitssystemen. Universitätsverlag der TU Berlin [11]
  • Blümel M, Busse R (2015): The German Health Care System, 2014. In: Mossialos E, Wenzl M, Osborn R, Anderson C (eds.) International Profiles of Health Care Systems, 2014, The Commonwealth Fund, January 2015 [12]
  • Röttger J et al (2015): Exploring Health System Responsiveness in Ambulatory Care and Disease Management and its Relation to Other Dimensions of Health System Performance (RAC) - Study Design and Methology [13]

2014

  • Baier N, Struckmann V (2014): Review zu den Perspektiven der ländlichen Versorgung. Ein Überblick international bestehender Ansätze. Working Papers in Health Policy and Management Vol. 9, 2014, Universitätsverlag der Technischen Universität Berlin [14]
  • Blümel M, Panteli D, van Ginneken E (2014): Assuring quality of inpatient care in Germany: existing and new approaches. EuroHealth 20 (3): 52-55 [15]
  • Busse R, Blümel M (2014): Germany: Health system review. Health Systems in Transition. 16(2): 1-296 [16]
  • Fuchs S, Henschke C, Blümel M, Busse R (2014): Disease-Management-Programme für Diabetes mellitus Typ 2 in Deutschland – Abschätzung der Effektivität anhand einer systematischen Literaturübersicht. Dt Ärzteblatt Int 111(26): 453-463 [17]
  • Garms-Homolová V, Busse R (2014): Monitoring the quality of long-term care in Germany. In: Mor V, Leone T, Maresso A (eds.) Regulating Long-term Care Quality: An International Comparison. Cambridge: Cambridge Univer­sity Press, p. 67-101 [18]
  • Siegel M, Vogt V, Sundmacher L (2014): From a conservative to a liberal welfare state: Decomposing changes in income-related health inequalities in Germany, 1994–2011. Soc Sci Med 108: 10-19 (DOI: 10.1016/j.socscimed.2014.02.022) [19]

2013

  • Busse R, Blümel M, Ognyanova D (2013): Das deutsche Gesundheitssystem. MWV Medizinisch Wissenschaftliche Verlagsgesellschaft mbH & Co.KG [20]
  • Busse R , Schreyögg J, Stargardt T (Hrsg.) (2013): Management im Gesundheitswesen. Das Lehrbuch für Studium und Praxis. 3., vollständig überarbeitete und erweiterte Auflage. Berlin-Heidelberg: Springer [21]
  • Busse R, Siegel M, Sundmacher L und die Mitglieder des Gesundheitsökönomischen Zentrums Berlin (2013): Gesundheitsökonomisches Zentrum Berlin (Berlin HECOR). Public Health Forum 21(4): 22.e1-22.e3 [22]

2012

2011

  • Busse R (2011): Das deutsche Gesundheitssystem: Schlecht, aber gut bewertet – oder gut, aber schlecht bewertet? Der Tagesspiegel, 18.11.2011 [23]
  • Busse R, Blümel M, Stock S (2011): The German Health Care System, 2011. In: THOMSON S, OSBORN R, SQUIRES D, REED SJ (eds.) [24]
  • Ognyanova D, Zentner A, Busse R (2011): Pharmaceutical reform 2010 in Germany: striking a balance between innovation and affordability. Eurohealth 17(1): 11-13 [25]
  • Scheller-Kreinsen D, Quentin W, Geissler A, Busse R (2011): DRG-type hospital payment systems in Europe: the German G-DRG system and the English Health Care Resources Groups (HRGs). In: Klusen N, ... [26]

2010

  • Busse R, Stock S (2010): The German Health Care system, 2009 [27]
  • Geissler A, Quentin W (2010): Prospective payment for inpatient psychiatric care. Health Policy Monitor, April 2010 [28]
  • Geissler A, Wörz M, Busse R (2010): Deutsche Krankenhauskapazitäten im internationalen Vergleich. In: KLAUBER J, GERAEDTS M, FRIEDRICH J (Hrsg.) Krankenhaus-Report 2010. Stuttgart: Schattauer, S. 25-40 [29]
  • Henschke C, Bäumler M, Gaskins M, Busse R: Coronary stents and the uptake of new medical devices in the German system of inpatient reimbursement. Journal of Interventional Cardiology 23(6): 546-553 [30]
  • Henschke C, Bäumler M, Weid S, Gaskins M, Busse R (2010): Extrabudgetary (‘NUB’) payments – A gateway for introducing new medical devices into the German inpatient reimbursement system? Journal of Management and Marketing in Healthcare 3(2): 119-133 [31]
  • Hoffmann C, van Ginneken E (2010): Substitution of prescribing rights in Germany. Health Policy, August 2010 [32]
  • Ognyanova D (2010): Migration von Gesundheitspersonal aus und nach Deutschland. In: Die Krankenversicherung. Berlin: Erich Schmidt Verlag 62: 152-154 [33]
  • Schreyögg J, Busse R (2010): Leistungsmanagement von Krankenversicherun-gen. In: BUSSE R, SCHREYÖGG J, TIEMANN O (Hrsg.) Management im Gesundheitswesen. Berlin: Springer-Verlag, S. 21-47 [34]
  • Schreyögg J, Weinbrenner S, Busse R (2010): Leistungsmanagement in der Integrierten Versorgung. In: BUSSE R, SCHREYÖGG J, TIEMANN O (Hrsg.) Management im Gesundheitswesen. Berlin: Springer-Verlag, S. 101-121 [35]
  • Tiemann O, Schreyögg J, Wörz M, Busse R (2010): Leistungsmanagement in Krankenhäusern. In: BUSSE R, SCHREYÖGG J, TIEMANN O (Hrsg.) Management im Gesundheitswesen. Berlin: Springer-Verlag, S. 47-76 [36]

2009

  • Busse R, Nimptsch U, Mansky T (2009) Measuring, Monitoring, And Managing Quality In Germany's Hospitals [37]
  • Busse R (2009): Wettbewerb im Gesundheitswesen – eine Gesundheitssystemperspektive. Z Evid Fortbild Qual Gesundheitswesen (ZEFQ) 103: 608–620 [38]
  • Blümel M, Busse R (2009): "Disease Management Programs – Time to evaluate". Health Policy Monitor, April 2009 [39]
  • Gaskins M, Busse R (2009): Morbidity-based risk adjustment in Germany: Long in coming, but worth the wait? Eurohealth 15(3): 29–31 [40]
  • Hoffmann C, van Ginneken E, Busse R (2009): "Better funding model for Inpatient Hospice Units". Health Policy Monitor, December 2009. [41]
  • Ognyanova D, Busse R (2009): "Health Fund now operational". Health Policy Monitor, May 2009 [42]
  • van Ginneken E, Busse R (2009): "Mandatory health insurance enacted". Health Policy Monitor, May 2009 [43]
  • Wörz M, Busse R (2009): Germany. In: Rapoport J, Jacobs P, Jonsson E (eds.) Cost Containment and Efficiency in National Health Systems: A Global Comparison [44]
  • Wörz M, van Ginneken E (2009): "Cross Sectoral Quality Assurance". Health Policy Monitor, October 2009 [45]
  • Zander B, Kimmerle J, Sundmacher L, Bäumler M. "Health Policy in Germany after the election". Health Policy Monitor, November 2009 [46]
  • Zentner A, Velasco Garrido M, Busse R (2009). Effekte des Gatekeeping durch Hausärzte - ein systematischer Review [47]
  • Zentner A, Velasco Garrido M, Busse R (2009). Macht der Hausarzt als Lotse die Gesundheitsversorgung wirklich besser und billiger? [48]

2008

  • Busse R (2008): The health system in Germany. Eurohealth 14(1): 5-6 [49]
  • Busse R (2008): Welche Anreizwirkung hat der Morbi-RSA hinsichtlich des Leistungs- und Qualitätsmanagements bei den Krankenkassen und Leistungserbringern? Deutsche Medizinische Wochenschrift 133(S05): S139 [50]
  • Bäumler M, Schreyögg J, Meissner S, Busse R (2008): References pricing for outpatient medical aids in Germany. Eurohealth 14(3): 9-11 [51]
  • Stargardt T, Busse R, Dauben H-P (2008): GERMANY. European Commission, Health and Consumer Protection Directorate-General and Austrian Ministry of Health, Family and Youth [52]

2006

  • Grabka M, Schreyögg J, Busse R (2006): Verhaltensänderung durch Einführung der Praxisgebühr und Ursachenforschung: Erste empirische Ergebnisse. Med Klin 101(6): 476-483 [53]
  • Schreyögg J, Tiemann O, Busse R (2006): Cost accounting to determine prices: how well do prices reflect costs in the German DRG-system? Health Care Management Science 9(3): 269-279 [54]
  • Weinbrenner S, Busse R (2006): Germany. In: Rechel B , Dubois C-A, McKee M (eds.) The Health Care Workforce in Europe – Learning from experience. Copenhagen/ Brussels: European Observatory on Health Systems and Policies, S. 33-46 [55]

2005

  • Busse R (2005): KV eignet sich besonders zur Koordination der Integrierten Versorgung. KV-Blatt Berlin 52(5): 17-18 [56]
  • Busse R (2005): Bedeutung von Health Technology Assessment bei Bewertungs- und Erstattungsentscheidungen in Deutschland heute und morgen. Gesundheitsökonomie & Qualitäts­management 10(S2): S52-S58 [57]
  • Busse R, Schreyögg J, Henke K-D (2005): Pharmaceutical Regulation in Germany: improving efficiency and controlling expenditures. International Journal of Health Planning and Management 20(4): 329-349 [58]
  • Busse R, Stargardt T, Schreyögg J (2005): Determining the benefit basket of the Statutory Health Insurance scheme in Germany: methodologies and criteria. European Journal of Health Economics 6(Suppl 1): 30-36 [59]
  • Altenstetter C, Busse R (2005): Healthcare reform in Germany: Patchwork change within established governance structures. J Health Politics Policy Law 30(1): 121-142 [60]
  • Schreyögg J, Busse R (2005): Disease management in Germany. EuroObserver 7(2): 3-4 [61]
  • Schreyögg J, Busse R (2005): Physician drug budgets in Germany: effects on prescription behaviour. Journal of Pharmaceutical Finance, Economics & Policy 14(3): 77-95 [62]
  • Schreyögg J, Tiemann O, Busse R (2005): The DRG reimbursement system in Germany. EuroObserver 7(4): 4-6 [63]
  • Velasco M, Borowitz M, Ovretveit J, Busse R (2005): Purchasing for quality care. In: Figueras J, Robinson R, Jakubowski E (eds.) Purchasing to improve Health Systems Performance. Buckingham: Open University Press, S. 215-235 [64]
  • Wörz M, Busse R (2005): Analysing the impact of health care system change in the EU member states - Germany. Health Economics 14(S1): S133-S149 [65]

2004

  • Busse R (2004): Disease Management Programs in Germany’s Statutory Health Insurance System - A Gordian Solution to the Adverse Selection of Chronically Ill in Competitive Markets? Health Affairs 23(3): 56-67 [66]
  • Busse R, Nolte E (2004): New citizens: East Germans in a united Germany. In: Healy J, McKee M (eds.) Accessing Healthcare - Responding to diversity. Oxford: Oxford University Press: 127-144 [67]
  • Busse R, Riesberg A (2004): Health care systems in transition: Germany. Copenhagen: WHO Regional Office for Europe on behalf of the European Observatory on Health Systems and Policies [68]
  • Busse R, Wörz M (2004): The ambiguous experience with privatisation in German health care. In: Maarse H (ed.) Privatisation in European health care - A comparative analysis in eight countries. Maarsen: Elsevier Gezondheidszorg, S. 79-95 [69]
  • Henke K-D, Borchardt K, Schreyögg J, Farhauer O (2004): Eine Systematisierung der Reformvorschläge zur Finanzierung der Krankenversorgung in Deutschland; Evaluating reform proposals for financing health care in Germany. Journal of Public Health 12(1):10 [70]
  • Schreyögg J (2004): Pfadabhängigkeit der Entscheidungsprozesse am Beispiel des deutschen Gesundheitswesens: Wirtschaftswissenschaftliches Studium (WiSt) 32(6): 360-364 [71]
  • Velasco Garrido M, Busse R (2004): Alemania: Calidad y Financiación de la Asistencia en Crisis. Ars Médica Revista de Humanidades 3(1): 57-73 [72]
  • Velasco Garrido M, Busse R (2004): Förderung der Qualität in deutschen Krankenhäusern? Eine kritische Diskussion der ersten Mindestmengen­vereinbarung. Gesundheits- und Sozialpolitik 58(5/6): 10-20 [73]
  • Velasco Garrido M, Wörz M, Busse R (2004): Ley de Modernización del Sistema Sanitario: la penúltima reforma alemana. Revista de Administración Sanitaria Siglio XXI 2(2): 287-298 [74]
  • Zentner A, Busse R (2004): Das Ausland in aller Munde - eine systematische Analyse zum Einfluss anderer Gesundheitssysteme auf die deutsche Reform­debatte. Gesundheits- und Sozialpolitik 58(9/10): 24-34 [75]

2003

  • Busse R, Wörz M (2003): Germany plans for “health care modernisation”. Eurohealth 9(1): 21-24 [76]
  • Dixon A, Riesberg A, Weinbrenner S, Saka O, Le Grand J, Busse R (2003). Complementary and alternative medicine in the UK and Germany: A synthesis of research and evidence on supply and demand. London, Berlin: Anglo-German Foundation [77]
  • Riesberg A, Busse R (2003): 120 Years of Social Health Insurance in German Health Care. Die BKK 91(8): 381-387 [78]
  • Riesberg A, Busse R (2003): Cost-shifting (and modernization) in German health care. EuroObserver 5(4): 4-5 [79]
  • Schreyögg J, Mackenthun B (2003): Selektives Kontrahieren als Chance zu alternativen Vergütungsformen im ambulanten Bereich. Public Health Forum 11(40) 17-18 [80]

2002

  • Busse R (2002): Germany. In: European Observatory on Health Care Systems (ed.) Health care systems in eight countries – trends and challenges. London: London School of Economics, p. 47-60 [81]
  • Busse R (2002): German health care reform - A Vademecum for confused outsiders. Forum für Gesundheitspolitik, Juli, S. 258-260 [82]
  • Busse R (2002): Health care systems: Germany and Britain compared/ Health care delivery - towards an agenda for policy learning between Britain and Germany. London: Anglo-German Foundation for the Study of Industrial Society [83]
  • Henke, K.-D, Mackenthun, B, Schreyögg, J. (2002): Gesundheitsmarkt Berlin– Perspektiven für Wachstum und Beschäftigung, Nomos-Verlag, Baden-Baden [84]
  • Orellano C (2002): German voters unsure about health of the nation. Lancet 360(9337): 930 [85]
  • Mackenthun, B, Schreyögg, J. (2002), Beschäftigungsperspektiven im Gesundheitswesen, in: Public Health Forum, Jg. 10 (2002), Nr. 34, S. 4-5 [86]
  • Thomson SMS, Busse R, Mossialos E (2002): Low demand for substitutive voluntary health insurance in Germany. Croatian Medical Journal 43(4): 425-432 [87]
  • Wörz M, Busse R (2002): Structural reforms for Germany’s health care system? EuroObserver 4(4): 1-3 [88]

2001

  • Busse R (2001): Risk structure compensation in Germany´s statutory health insurance. Eur J Public Health 11(2): 74-77 [89]
  • Busse R (2001): Reformas en el sistema sanitario Aleman. Revista de Administracion Sanitaria V(17): 45-69 [90]
  • Busse R (2001): The German health care system – An introductory description. In: Henke K-D, Dräger C (eds.) Gesundheitssysteme am Scheideweg: Zwischen Wettbewerb und Solidarität. Edition Dräger-Stiftung Vol. 17. Baden-Baden: Nomos, p. 17-35 [91]
  • Perleth M, Busse R, Gibis B, Brand A (2001): Evaluation of preventive technologies in Germany – Case studies on mammography, prostate cancer screening and fetal ultrasound. Int J Technology Assessment Health Care 17(3): 329-337 [92]
  • Wörz M, Wismar M (2001): Green politics in Germany: what is Green health care policy? Int J Health Serv 31(4): 847-867 [93]

2000

  • Busse R (2000): Health care systems in transition – Germany. Written in collaboration with A. Riesberg and edited by A. Dixon; also in German and Russian. Copenhagen: European Observatory on Health Care Systems [94]
  • Busse R (2000): Germany. In: Wieners WW (ed.) Global health care markets: A comprehensive guide to regions, trends, and oppor­tu­ni­ties shaping the inter­national health arena. San Francisco: Jossey Bass, p. 139 [95]
  • Perleth M, Busse R (2000): Health technology assessment in Germany: Status, challenges, and development. Int J Technology Assessment Health Care 16(2): 412-428 [96]

1999

  • Busse R (1999): Priority-setting and rationing in German health care. Health Policy 50(1/2): 71-90 [97]
  • Perleth M, Busse R, Schwartz FW (1999): Regulation of health-related technologies in Germany. Health Policy 46(2): 105-126 [98]
  • Busse R, Schwartz FW (1999): Decision-Making and Priority-Setting in Public Health and Health Care in Germany. In: Holland W, Mossialos E, Belcher P, Merkel B (eds.) Public Health Policies in the European Union. Aldershot: Ashgate, p. 105-126 [99]
  • Busse R, Howorth C (1999): Cost containment in Germany: twenty years experience. In: Mossialos E, LeGrand J (eds.) Health care and cost containment in the European Union. Aldershot: Ashgate, p. 303-339 [100]

1997

  • Busse R, Howorth C, Schwartz FW (1997): The future development of a rights based approach to health care in Germany: more rights or fewer? In: Lenaghan J (ed.) Hard Choices in Health Care - Rights and Rationing in Europe. London: BMJ Publishing Group, p. [101]
  • Busse R, Schwartz FW (1997): Financing reforms in the German hospital sector - From full cost cover principle to prospective case fees. Med Care 35(10): OS40-OS49 [102]
  • Busse R, Schwartz FW (1997): The Philippines' National Health Insurance Act - a German Perspective. Int J Health Planning and Management 12(2): 131-148 [103]
  • Schwartz FW, Busse R (1997): Germany. In: Ham C (ed.) Health Care Reform: Learning from International Experience. Buckingham-Philadelphia: Open University Press, p. 104-118 [104]

Nach oben

------ Links: ------

Zusatzinformationen / Extras

Direktzugang

Schnellnavigation zur Seite über Nummerneingabe

Copyright TU Berlin 2008